US 9751921
Apelin fusion proteins and uses thereof
granted A61KA61K38/00A61P
Quick answer
US patent 9751921 (Apelin fusion proteins and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00, A61P, A61P3/04, A61P3/10